- This event has passed.
Webinar: The Technology Revolution in Healthcare is in Sight: Realizing an AI-driven, Compliant, Equitable, Connected Healthcare Ecosystem
September 27 @ 9:00 am – 10:00 am
The Technology Revolution in Healthcare is in Sight: Realizing an AI-driven, Compliant, Equitable, Connected Healthcare Ecosystem
Wednesday, September 27, 2023 ● 9:00 a.m.-10:00 a.m.
The speed of innovation and acceleration in healthcare is nothing like we have ever seen before. The industry was picking up speed prior to the COVID-19 pandemic and since then we have seen an acceleration in everything from telemedicine, to decentralized clinical trials, to AI applied to everything from drug discovery to commercialization. That leaves us both with an amazing opportunity to solve some of the greatest healthcare challenges but also brings new complexities and issues we need to tackle from a privacy, security, legal and ethical standpoint. It will take everyone to both realize the potential and ensure we move forward in a measured and responsible way that does not hold back the very innovation that will save lives – why we all do what we do every day!
Join BioNJ and industry leaders on September 27 to dive into these topics with a focus on how we can all start to apply new technologies even in the smallest ways to make progress forward in what will prove to be one of the most dynamic eras of healthcare ahead.
Reed Abrahamson, Partner, Faegre Drinker
As a member of Faegre Drinker’s FDA Regulatory Team, Reed advises clients in the life sciences industry, including major pharmaceutical, biotechnology and medical device companies, on a wide range of issues associated with clinical trials and research. He assists in the development and negotiation of clinical trial agreements, informed consent forms and other important research documents. Additionally, Reed supports companies as they contract with research vendors and collaboration partners, as well as helps companies implement privacy and security measures to support clinical trials and medical research.
Lynne Anderson, Partner, Faegre Drinker
Lynne has a long history of working with life sciences/pharmaceutical clients. She is an experienced jury and bench trial lawyer with a track record of success in whistleblower/retaliation cases, discrimination claims, wage and hour class/collective actions and restrictive covenant disputes. Lynne’s litigation background provides the insight to effectively counsel clients who are dealing with strategic planning and frontline employee issues. She is Co-Chair of the BioNJ’s HR Committee and founding member and Co-Chair of BioNJ’s Inspiring Women of STEM Committee.
Romain Bogaerts, Director, AI Product Management, Real Chemistry
Romain’s team builds both internal facing AI solutions and external AI products for life sciences companies. Internally, the team has developed a Generative AI platform and other AI algorithms that empower the agency side of Real Chemistry to become exponentially more insightful. For clients, Romain leads the design and development of innovative products: AdTech capabilities for Swoop to target the right Patient and HCP audiences, HealthTech products at ipm.ai to identify undiagnosed Patients in specialty and MarTech data products that link SDOH and social media data to measure the impact of campaigns.
Jennifer Gottlieb, Global President, Chief Client Officer, Real Chemistry
Jennifer is the Global President, Chief Client Officer and member of the Board of Directors of Real Chemistry, the leading provider of AI-driven insights and human-centric experiences for the healthcare industry. A healthcare pioneer — Jennifer’s career has been dedicated to driving strategic communications and commercial initiatives for clients in the pharmaceutical and biotechnology sectors as they navigate the ever-changing industry landscape. Jennifer takes on bold challenges, including realizing the company’s vision to use AI and Ideas to transform the healthcare experience from what it is to what it should be.